Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
Ashorn
P
P
Department of Biochemical Sciences, University of Tampere, Finland.
Berger
E A
EA
Moss
B
B
D000818:Animals; D015704:CD4 Antigens / Q000378:metabolism*; D002460:Cell Line; D015686:Gene Products, env / Q000378:metabolism*; D015752:Genes, env; D005822:Genetic Vectors; D015726:Giant Cells / Q000502:physiology; D015699:HIV Envelope Protein gp120 / Q000378:metabolism; D019302:HIV Envelope Protein gp160; D015700:HIV Envelope Protein gp41 / Q000378:metabolism; D015497:HIV-1 / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008561:Membrane Fusion; D011498:Protein Precursors / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D014616:Vaccinia virus
D015704:CD4 Antigens; D015686:Gene Products, env; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D015700:HIV Envelope Protein gp41; D011498:Protein Precursors; D011994:Recombinant Proteins